Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKesson
Dow
Johnson and Johnson
Boehringer Ingelheim

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016084

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 016084 describes ZYLOPRIM, which is a drug marketed by Casper Pharma Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the ZYLOPRIM profile page.

The generic ingredient in ZYLOPRIM is allopurinol. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
Summary for 016084
Tradename:ZYLOPRIM
Applicant:Casper Pharma Llc
Ingredient:allopurinol
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016084
Mechanism of ActionXanthine Oxidase Inhibitors
Medical Subject Heading (MeSH) Categories for 016084
Suppliers and Packaging for NDA: 016084
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYLOPRIM allopurinol TABLET;ORAL 016084 NDA Casper Pharma LLC 70199-015 70199-015-90 90 TABLET in 1 BOTTLE (70199-015-90)
ZYLOPRIM allopurinol TABLET;ORAL 016084 NDA Casper Pharma LLC 70199-016 70199-016-05 500 TABLET in 1 BOTTLE (70199-016-05)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 016084

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Casper Pharma Llc ZYLOPRIM allopurinol TABLET;ORAL 016084-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Colorcon
Merck
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.